These results imply that Trm cell-mediated melanoma rejection triggers the spreading of CD8+ T-cell responses against melanoma-associated antigens, providing cross-protection against melanoma lacking Trm cell-targeted antigen. This evidence concerns the gene CD8A and melanoma.